Navigation Links
NeuroCog Trials Appoints Industry Executive Michael Hufford, Ph.D. to Chief Operating Officer
Date:11/4/2011

Dr. Hufford received his B.A. with Distinction in psychology from Purdue University, and his M.S. and Ph.D. in clinical psychology from the University of Pittsburgh.  Subsequently, he was a Clinical and Research Fellow in Department of Psychiatry at Harvard Medical School at the McLean Hospital.  Dr. Hufford has more than 90 scientific publications and presentations, with multiple issued and pending patents.

About NeuroCog Trials

NeuroCog Trials Inc. is the leading cognition services company for the pharmaceutical industry.  For more than 10 years, NeuroCog Trials has provided consulting, site screening, rater training and certification, and data review services to more than 50 clinical trials in over 25 countries.  NeuroCog Trials has certified more than 4,000 neurocognitive testers and assured data quality for over 50,000 assessments across a variety of therapeutic areas, including schizophrenia, Alzheimer's disease, major depressive disorder, bipolar disorder and brain cancer.  Our mission is to facilitate the development of novel therapies to enhance cognition.  We bring to all of our work deep expertise, strategic innovation, and an unwavering commitment to research excellence.

For more information on NeuroCog Trials, its services, and licensing inquiries for its exclusive neuropsychological and functional capacity assessment batteries, please see www.neurocogtrials.com

CONTACT
Richard Keefe, Ph.D.
Founder & CEO
NeuroCog Trials
(919) 401-4642


'/>"/>
SOURCE NeuroCog Trials, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Data From REMEDEE Trial Featuring OrbusNeichs Combo™ Dual Therapy Stent to be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011
2. CTRI Confirms Leading Indian CRO Supports Majority of Hemophilia Trials in India
3. QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers
4. Kibow Biotech, Inc. Secures $2.4 Million Towards Its Human Clinical Trials by Continued Veterinary Licensing Agreement
5. Middle East to be the Future in Clincial Trials
6. Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule Revamilast
7. Start of in-Patient Clinical Trials With NT-KO-003, the First Neuroprotective Drug for Multiple Sclerosis Without Immunosuppressive Effects
8. Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe
9. Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International
10. ERA-EDTA Congress 2011: Late Breaking Clinical Trials I
11. ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardts Disease and Dry Age-Related Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... PARK, Calif. , July 24, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, ... webcast of a presentation to investors on Tuesday, ... p.m. PDT.  The presentation will include an overview ... To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... of Engineering at the University of Delaware, is ... in energy engineering, environmental sustainability and electronics. , ... rock with a well-defined, crystalline structure. At the ... decided that zeolites can separate molecules with size ... (one-tenth of a nanometer), making them useful to ...
(Date:7/24/2014)... 24, 2014 SRI International has been awarded ... Institute of Allergy and Infectious Diseases (NIAID), part of ... of potential therapies for HIV infection and AIDS. The ... and AIDS and the complications and opportunistic infections associated ... sexual transmission of HIV. According to ...
(Date:7/24/2014)... July 24, 2014 WIRB-Copernicus Group ® ... and ethical review services for clinical research, announced ... a division of Richmond, VA ... biosafety and biosecurity consulting firm in ... WCG,s biosafety division – WCG Biosafety™ – will ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4University of Delaware researcher describes new approach for creating organic zeolites 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3
... Bernd Eschweiler and Beate Kilb, Institute for Water Research, Schwerte, Germany , ... Introduction , Bacterial diversity in environmental ... of isolated strains. A problem for the analysis and , ... most of the bacteria species present in the sample. Therefore isolated ...
... , Tochigi Cancer Center, Tochigi, Japan , ... Introduction , Denaturing gradient gel electrophoresis (DGGE) ... scanning methods. It has evolved enormously over the last , ... A practical method on this topic has been reported recently. 1 The ...
... Ibrahim Buyuksal, and William S. Dalton,H. Lee Moffitt Cancer Center and Research Institute, ... , ... Identifying of mutations within specific genes has become an important , ... many diseases, , including cancer. Several ...
Cached Biology Technology:Microbial Diversity in Ground and Surface Water Analyzed by Denaturing Gradient Gel Electrophoresis Using the DCode System 2Microbial Diversity in Ground and Surface Water Analyzed by Denaturing Gradient Gel Electrophoresis Using the DCode System 3Microbial Diversity in Ground and Surface Water Analyzed by Denaturing Gradient Gel Electrophoresis Using the DCode System 4Detection of p53 Gene in Breast Cancer by Denaturing Gradient Gel Electrophoresis and the DCode System 2Detection of p53 Gene in Breast Cancer by Denaturing Gradient Gel Electrophoresis and the DCode System 3Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis 2Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis 3Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis 4Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis 5
(Date:7/25/2014)... 1 (NRG1) is a pleiotropic factor characterized by ... splicing of exons that confer to the protein ... for both the myelination occurring during development and ... peripheral nerve: axon degeneration, axon regrowth, remyelination and ... Australia have discovered that the soluble NRG1 upregulation ...
(Date:7/25/2014)... a molecular testing panel developed at UPMC greatly ... surgery for patients with thyroid nodules and cancer, ... Institute (UPCI), partner with UPMC CancerCenter., The test, ... other diagnostic testing agencies, improved the chances of ... percent, according to the study published this month ...
(Date:7/24/2014)... York, NY - July 24, 2014 -- Keryx Biopharmaceuticals, ... from the long-term, randomized, active control Phase 3 study ... iron-based phosphate binder, for the treatment of hyperphosphatemia in ... PERFECTED study (PhosphatE binding and iRon delivery with FErric ... Journal of the American Society of Nephrology ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
... evolutionary paradigm, Luiz Rocha and colleagues from the Smithsonian ... and the University of Hawaii, report coral reef fish ... than from fish thousands of miles away. An ecological ... development of a more synthetic treatment of speciation on ...
... the mouth and throat, surgery is a frequent ... swallowing dysfunction and external scarring. Researchers from the ... Otorhinolaryngology/Head and Neck Surgery, have completed two studies ... demonstrate the effective use of the daVinci Surgical ...
... of Medicine in St. Louis have learned that a ... successes in treating diabetic rats with embryonic pig tissues. ... surprised to find that they didn't have to give ... cell transplants. They had expected rats that received no ...
Cached Biology News:An (ecological) origin of species for tropical reef fish 2Penn Researchers Use Robotic Surgery 2Penn Researchers Use Robotic Surgery 3Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 3
... ESGRO Complete Derivation Kit is intended ... cells from delayed blastocysts in serum-free ... Clonal Grade ... Blastocyst Incubation Medium Trypsin Solution ...
AedestaTM Animal Organ/Tissue Perfusion Soln....
RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2...
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
Biology Products: